AC
VBIV

Athanor Capital’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Athanor Capital’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,124
Closed -$175K – 1080
2020
Q4 		$175K Sell
2,124
-862
-29% -$73.5K ﹤0.01% 675
2020
Q3 		$256K Sell
2,986
-1,260
-30% -$147K 0.01% 454
2020
Q2 		$395K Buy
+4,246
New +$234K 0.02% 350
2020
Q1 		– Sell
-3,894
Closed -$161K – 375
2019
Q4 		$161K Buy
+3,894
New +$85.3K 0.01% 358

Other funds holding VBIV

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Athanor Capital's VBIV Position: Q1 2021 in Review

Athanor Capital sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q1 2021, closing a stake of 2,124 shares — an estimated $175K sold.

Athanor Capital first reported a position in VBIV in Q4 2019 and held it in 4 quarters. The position peaked at $395K in Q2 2020. 137 funds tracked by Wall St. Rank hold VBIV as of Q1 2021.

  • Athanor Capital reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q1 2021 after selling out during the quarter.
  • Athanor Capital sold 2,124 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q1 2021, an estimated $175K.
  • Athanor Capital first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q4 2019 and held it in 4 quarters.
  • Athanor Capital's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $395K in Q2 2020.
  • 137 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q1 2021.

Based on Athanor Capital's 13F filing for Q1 2021, filed 14 May 2021.